The Interaction and Mediation Effects Between the Host Genetic Factors and Epstein–Barr Virus VCA‐IgA in the Risk of Nasopharyngeal Carcinoma

Hua Diao,Wen-Qiong Xue,Tong-Min Wang,Da-Wei Yang,Chang-Mi Deng,Dan-Hua Li,Wen-Li Zhang,Ying Liao,Yan-Xia Wu,Xue-Yin Chen,Ting Zhou,Xi-Zhao Li,Pei-Fen Zhang,Xiao-Hui Zheng,Shao-Dan Zhang,Ye-Zhu Hu,Su-Mei Cao,Qing Liu,Wei-Min Ye,Yong-Qiao He,Wei-Hua Jia
DOI: https://doi.org/10.1002/jmv.29224
IF: 20.693
2023-01-01
Journal of Medical Virology
Abstract:Previous studies have demonstrated strong associations between host genetic factors and Epstein-Barr virus (EBV) VCA-IgA with the risk of nasopharyngeal carcinoma (NPC). However, the specific interplay between host genetics and EBV VCA-IgA on NPC risk is not well understood. In this two-stage case-control study (N = 4804), we utilized interaction and mediation analysis to investigate the interplay between host genetics (genome-wide association study-derived polygenic risk score [PRS]) and EBV VCA-IgA antibody level in the NPC risk. We employed a four-way decomposition analysis to assess the extent to which the genetic effect on NPC risk is mediated by or interacts with EBV VCA-IgA. We consistently found a significant interaction between the PRS and EBV VCA-IgA on NPC risk (discovery population: synergy index [SI] = 2.39, 95% confidence interval [CI] = 1.85-3.10; replication population: SI = 3.10, 95% CI = 2.17-4.44; all pinteraction  < 0.001). Moreover, the genetic variants included in the PRS demonstrated similar interactions with EBV VCA-IgA antibody. We also observed an obvious dose-response relationship between the PRS and EBV VCA-IgA antibody on NPC risk (all ptrend  < 0.001). Furthermore, our decomposition analysis revealed that a substantial proportion (approximately 90%) of the genetic effects on NPC risk could be attributed to host genetic-EBV interaction, while the risk effects mediated by EBV VCA-IgA antibody were weak and statistically insignificant. Our study provides compelling evidence for an interaction between host genetics and EBV VCA-IgA antibody in the development of NPC. These findings emphasize the importance of implementing measures to control EBV infection as a crucial strategy for effectively preventing NPC, particularly in individuals at high genetic risk.
What problem does this paper attempt to address?